Predicting liver recovery with spleen stiffness and blood tests
Part of Digestive system, Infections clinical trials.
This study looks at whether measuring spleen stiffness and simple blood tests can predict if the liver will recover in people with decompensated cirrhosis. It may help doctors know which patients can improve with treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with decompensated cirrhosis (liver scarring with complications).
- Your first liver complication happened within the last 12 months, or you have not had any liver complications in the past year.
- You are receiving effective treatment for the cause of your cirrhosis, such as antiviral therapy for hepatitis B, abstinence from alcohol for at least 2 months, or lifestyle changes for fatty liver disease.
- You have not had a liver transplant, TIPS procedure, spleen removal, or certain shunt surgeries.
- You do not have liver cancer, recent bleeding from varices, or severe fluid buildup in the belly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people over 18 who have advanced, long-term liver scarring. It uses specialized measurements of liver stiffness and pressure to confirm eligibility and may help doctors better understand this condition.
This study looks at how well a simple score (called SSM) can predict recovery in people with chronic liver disease who suddenly get a liver injury with jaundice. It may help your doctors understand how serious your condition is.
This study uses a simple ultrasound-based test (FibroScan) to check liver stiffness and predict whether you have high pressure in the veins around the liver. It aims to see if a new set of criteria can safely tell who needs an endoscopy, helping avoid unnecessary procedures.
This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
Hear when a new Decompensated Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.